# A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C

> **NCT00144469** · PHASE3 · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 300 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** peginterferon alfa-2a
- **DRUG:** rivavirin

## Key facts

- **NCT ID:** NCT00144469
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2009-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144469, "A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00144469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*